CME Group Inc. is moving to a sole listing with the Nasdaq OMX Group Inc., eliminating its listing on the New York Stock Exchange.
The Chicago-based parent company of the Chicago Mercantile Exchange and the Chicago Board of Trade, which has listed its shares on the NYSE since it went public in 2002, will cease listing on the NYSE on July 11, but will continue to use its “CME” ticker symbol.
Under the terms of the deal, Nasdaq OMX of New York will extend CME Group’s exclusive rights to offer futures and options on futures contracts based on Nasdaq indices by seven years, until 2019.
CME also has exclusive rights to offer futures and options on indexes from Standard & Poor’s of New York until 2016 and on indexes from Dow Jones & Co. Inc. of New York until 2014.
“[The] extension of CME Group's exclusive license rights further strengthens our long-term growth prospects and earnings potential in the equity derivatives market,” CME chief executive Craig Donohue said in a statement.
No comments:
Post a Comment